KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Free Cash Flow (2016 - 2025)

LifeMD filings provide 14 years of Free Cash Flow readings, the most recent being -$2.9 million for Q4 2025.

On a quarterly basis, Free Cash Flow rose 33.8% to -$2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $201636.0, a 98.13% decrease, with the full-year FY2025 number at $201636.0, down 98.13% from a year prior.
Free Cash Flow hit -$2.9 million in Q4 2025 for LifeMD, up from -$2.9 million in the prior quarter.
In the past five years, Free Cash Flow ranged from a high of $9.9 million in Q3 2024 to a low of -$12.5 million in Q2 2022.
Median Free Cash Flow over the past 5 years was -$2.9 million (2025), compared with a mean of -$2.2 million.
Biggest five-year swings in Free Cash Flow: plummeted 1644.08% in 2021 and later skyrocketed 1363.81% in 2025.
LifeMD's Free Cash Flow stood at -$5.8 million in 2021, then soared by 176.45% to $4.4 million in 2022, then dropped by 18.17% to $3.6 million in 2023, then crashed by 222.01% to -$4.4 million in 2024, then soared by 33.8% to -$2.9 million in 2025.
The last three reported values for Free Cash Flow were -$2.9 million (Q4 2025), -$2.9 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.